Developer docs
API playgroundTry for free, no card

Search company profiles

Quest Diagnostics Foundation

Full company profile

uuid003hyfu

Namestring
Quest Diagnostics Foundation
Legal namestring
Quest Diagnostics Incorporated
Company typeenum
Public
Founded yearint
1991
Descriptiontext

Quest Diagnostics Foundation is the 501(c)(3) charitable arm of Quest Diagnostics Incorporated (NYSE: DGX), a leading U.S. diagnostic information services company. Founded in 1991, the Foundation promotes healthcare and wellness through community health initiatives and has committed approximately $53 million to such programs since 2021, including a $5 million multi-year partnership with Miami-Dade County. The Foundation operates without a separate parent entity, and its funded work — including deployments such as the U.S. Hunger AI-powered Full Cart Connect food-as-medicine platform — is resourced by the operating parent company.

The underlying operating company, Quest Diagnostics, provides clinical laboratory testing and diagnostic information services including molecular/PCR testing, serology, genetic testing, anatomic pathology, advanced genomics, and reproductive and women's health testing. It operates 2,000+ patient service centers and 7,700 patient access points, performs more than 200 million tests annually, and serves roughly half of U.S. physicians and hospitals. Specialty subsidiaries include AmeriPath (anatomic pathology), Cleveland HeartLab (cardiometabolic), Athena Diagnostics (neurology), Blueprint Genetics (rare-disease genetics, 70+ countries), PhenoPath and Dermpath Diagnostics (dermatopathology), Haystack Oncology (ctDNA MRD liquid biopsy, acquired 2023), and Pack Health (digital patient engagement, acquired 2022). The technology stack spans proprietary assay development, integrations with 850+ EHR systems, the Quest AI Companion for patient result interpretation, and AI-empowered analytics within Blueprint Genetics.

The business model is transaction-based, with per-test pricing billed primarily through payer reimbursement (the company reports in-network coverage of 90% of insured lives) and a growing direct-to-consumer channel via questhealth.com. Customer segments span physicians, hospitals and health systems, employers, health plans, life sciences companies, and individual consumers. Reported revenue was $9.88 billion in 2022 (elevated by COVID-19 testing) and was guided to $8.93B–$9.08B for 2023, with disclosed commentary indicating that base-business revenues were growing as pandemic-related testing volumes normalized.

Short descriptiontext

Quest Diagnostics Foundation is the 501(c)(3) charitable arm of Quest Diagnostics Incorporated (NYSE: DGX). The parent operates a national clinical laboratory network running 200+ million tests per year for half of U.S. physicians and hospitals, and the Foundation funds community health and wellness programs in partnership with public health and anti-hunger organizations.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
5,001–10,000
akta.pro rankint
HeadquartersSecaucus, United States
HQ citystring
Secaucus
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices8 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
community health grants, health equity programs, disease prevention funding, charitable health partnerships, community wellness initiatives
Industry2 codes
1Health & Medical Research Grantmaking Foundations
CodeBPAGAKALPrimaryYes
2Community Health, Prevention & Health Education
CodeBPAGACACPrimaryNo
NAICS code2 codes
  • Grantmaking Foundations813211
  • Voluntary Health Organizations813212
SIC code1 code
  • Services-Social Services8300
Product category
Healthcare Philanthropy
GTM motion4 records

Each record includes

Type, Description, Source

Revenue model5 records
1Diagnostic Information Services
TypeSubscription Recurring
Description

Clinical laboratory testing services provided to healthcare providers and patients, including routine and specialty tests across multiple disease categories.

newsroom.questdiagnostics.com
2COVID-19 Testing
TypeTransaction Fee
Description

Molecular (PCR), rapid antigen, and antibody testing for SARS-CoV-2, with revenues declining post-pandemic from peak levels.

newsroom.questdiagnostics.com
3Consumer-Initiated Testing
TypeTransaction Fee
Description

Direct-to-consumer lab tests purchased online through questhealth.com without doctor's order, including STI self-collection and various panel tests.

questdiagnostics.com
4Enterprise/B2B Services
TypeManaged Services
Description

Laboratory services for hospitals, health systems, employers, health plans, and life sciences companies including drug screening, population health, and clinical trials.

questdiagnostics.com
5Base Business Revenues
TypeSubscription Recurring
Description

Core diagnostic testing revenues excluding COVID-19 testing, representing routine and specialty laboratory services.

newsroom.questdiagnostics.com
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels6 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Operations, Personnel, Marketing or Sales, Others
Pricing details3 tiers
1Standard diagnostic testing services
ModelTransaction based/ take rateBilling cadencePay-as-you-go
Notes

Pricing based on specific test codes; in-network with 90% of insured lives; self-pay price estimates available at patient.questdiagnostics.com/estimate

questdiagnostics.com
2Consumer-initiated testing (questhealth.com)
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Direct consumer purchase of 150+ lab tests online without doctor's visit; various price points for different test panels

questdiagnostics.com
3Financial assistance programs
ModelOtherBilling cadencePay-as-you-go
Notes

Financial assistance available for eligible patients; $0 out-of-pocket for qualified uninsured patients via CDC ICATT program

questdiagnostics.com
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 9 records shown
1Quanum Lab Services Manager
Description

Online business tool for physicians, hospital, and office staff to order lab tests and view patient results

questdiagnostics.com
+8 more records
Core offering1 text field

Quest Diagnostics Foundation is a 501(c)(3) nonprofit corporation that promotes healthcare and wellness benefits and disease prevention through grant-making and community health initiatives. The Foundation has committed approximately $53 million to community initiatives since 2021, awarding grants to nonprofits in cities such as Baltimore, Houston, Chicago, Paterson, and Miami-Dade County, with a focus on maternal health, cardiometabolic outcomes, food security, and health equity in underserved communities.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • ApoB testing rates doubled between 2021-2023, reaching 1.8% of at-risk patients, though still extremely low relative to standard lipid panel testing
+2 more records
Product overview1 text field

Quest Diagnostics is a diagnostic information services company offering a comprehensive portfolio of laboratory tests and health technology solutions. The core offerings include MyQuest patient portal and Quanum Lab Services Manager for healthcare providers. Key specialty brands include AmeriPath (anatomic pathology), Cleveland HeartLab (cardiometabolic testing), Athena Diagnostics (neurological testing), Blueprint Genetics (genetic testing), and PhenoPath/Dermpath Diagnostics (dermatopathology/cancer diagnostics). The company recently acquired Haystack Oncology for minimal residual disease (MRD) liquid biopsy testing. Additional services include health coaching through Pack Health, thousands of routine and specialty lab tests, and population health solutions. Quest serves half of U.S. physicians and hospitals, with approximately 3,500+ lab tests available across 2,000+ patient service centers.

Product and service4 records
1Community Health Grants Program
CategoryGrant programs
Description

Grant-making program through which the Foundation awards funding to community-based nonprofit organizations working on health equity, maternal health, cardiometabolic disease prevention, and food security in underserved U.S. communities.

2Healthy Communities Champions Award
CategoryAwards and recognition
Description

Recognition program honoring up to 15 individuals or organizations committed to improving health in their communities, each receiving a $5,000 grant to support their community health work.

3Miami-Dade County Health Initiative
CategoryCommunity health initiatives
Description

Multi-year initiative committing nearly $5 million in grant funding to four local nonprofit organizations in Miami-Dade County, Florida, to improve chronic and maternal health outcomes and food security, with a goal of reaching up to 15,000 residents over a 2-year period.

4Multi-Year Health Equity Initiative
CategoryStrategic community health programs
Description

Joint $100+ million initiative launched by Quest Diagnostics and the Foundation to improve health, with initial focus on communities hit hardest by COVID-19 and continuing focus on health equity, chronic disease prevention, and community health workforce.

Scale indicator16 records

Each record includes

Type, Value, Description, Source

Partnership11 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-06-29
Description

$5 million foundation grant for maternal health services across Miami-Dade County maternal health deserts, expanding Black Mothers Care Plan through mobile units and midwifery services.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-06-29
Description

Foundation grant recipient coordinating Food and Nutrition for All Collaborative (FNFA), strengthening governance and shared data infrastructure, supporting mini-grants for up to 16 community organizations.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-06-29
Description

Foundation grant recipient serving as evaluation partner to measure effectiveness of initiative, conducting equity-focused analysis of food access, maternal health, and chronic disease prevention.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-06-29
Description

Foundation grant recipient deploying AI-powered Full Cart Connect Platform to identify and direct support to households in need throughout Miami-Dade County.

Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2026-06-18
Description

Collaborative research on antibiotic-resistant bacteria. Quest provided deidentified culture isolates from nationwide network for CDI sequencing analysis. Study published in Nature Communications identified multidrug-resistant Klebsiella pneumoniae spread across 42 states.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-04-27
Description

Quest acquired Haystack Oncology for $300 million (plus up to $150M milestones) to add minimal residual disease (MRD) liquid biopsy testing. Haystack developed tumor-informed ctDNA technology based on 20 years of Johns Hopkins research for early detection of residual or recurring cancer.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-04-17
Description

Quest completed acquisition of select laboratory services assets of NewYork-Presbyterian. Goal is to enable providers and patients to access high quality, affordable testing combining complementary strengths of both organizations with access to Quest's network of nearly 100 patient service centers.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-02-16
Description

Quest provides laboratory supply chain expertise and reference testing for regional integrated healthcare system in Pennsylvania.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-01-18
Description

Quest acquired Pack Health to add digital patient engagement and health coaching capabilities. Pack Health provides health coaching for chronic disease management programs, including diabetes, and expanded headquarters in Birmingham, Alabama with at least 200 new full-time jobs.

Strategic tierFlagshipTypeStrategic or Co-development Partner
Description

Quest is the only major laboratory provider in CDC's Increasing Community Access to Testing program supporting testing access for uninsured in underserved communities.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Community partnership delivering healthcare services to vulnerable children in Chicago through mobile van services.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Corporate foundation of a major pharmaceutical company funding community health, health workforce, and health-equity initiatives globally. Same corporate-foundation structure, comparable grant size, and overlap in target disease areas (cardiovascular, infectious disease).

TypeDirect peer
Description

Corporate foundation of a major pharmaceutical company supporting community health and disease-specific initiatives. Direct structural peer as a publicly traded pharma parent with a separately governed corporate foundation.

TypeBroad incumbent
Description

The largest US philanthropy focused exclusively on health, RWJF funds community health, maternal/child health, and health-equity initiatives across many markets. It is the benchmark independent health-focused grantmaking foundation and the most relevant peer for the Quest Diagnostics Foundation's mission and grantmaking model.

TypeDirect peer
Description

A major pharmaceutical corporate foundation funding health-equity, oncology, and cardiovascular community programs. Closely comparable in structure as a corporate-foundation grantmaker, with similar disease-area and disparities focus and grantee-driven delivery model.

TypeDirect peer
Description

Community health arm of a large integrated US health system, funding community health, maternal/child health, and chronic disease prevention in served and underserved markets. Comparable as a healthcare-organization grantmaker targeting similar disease areas and populations.

TypeDirect peer
Description

Corporate foundation of a major US health insurer funding community health, maternal/child health, and workforce initiatives. Closely comparable scale, grantmaking structure, and disease-area focus to the Quest Diagnostics Foundation.

TypeDirect peer
Description

Nonprofit academic clinical laboratory affiliated with the University of Utah, providing reference and esoteric diagnostic services. Closely comparable in business model (diagnostics) and nonprofit structure, making it the closest structural peer if the comparison expands to the Foundation's parent context.

TypeBroad incumbent
Description

Independent nonprofit that mobilizes philanthropic and private-sector resources to support CDC priorities in public health, health equity, and disease prevention. Comparable as a public-health-focused grantmaking organization, though with broader public-sector and global scope.

TypeBroad incumbent
Description

Global clinical laboratory and diagnostic services company with US operations through affiliated brands. Comparable to Quest Diagnostics at the parent-company level in core diagnostics business, providing indirect context for the Foundation's strategic priorities.

TypeBroad incumbent
Description

Direct competitor to Quest Diagnostics Incorporated (the parent of the Foundation) in clinical laboratory services. Most relevant peer for the broader organization, though Labcorp's corporate foundation activities are a subset of its scale.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers7 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment7 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

Integration5 records

Each record includes

Title, Type, Description, Source

AI capability5 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature9 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries9 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment3 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Quest Diagnostics Foundation

Healthcare Philanthropyquestdiagnostics.com

Quest Diagnostics Foundation is the 501(c)(3) charitable arm of Quest Diagnostics Incorporated (NYSE: DGX). The parent operates a national clinical laboratory network running 200+ million tests per year for half of U.S. physicians and hospitals, and the Foundation funds community health and wellness programs in partnership with public health and anti-hunger organizations.

What Quest Diagnostics Foundation does

Quest Diagnostics Foundation is the 501(c)(3) charitable arm of Quest Diagnostics Incorporated (NYSE: DGX), a leading U.S. diagnostic information services company. Founded in 1991, the Foundation promotes healthcare and wellness through community health initiatives and has committed approximately $53 million to such programs since 2021, including a $5 million multi-year partnership with Miami-Dade County. The Foundation operates without a separate parent entity, and its funded work — including deployments such as the U.S. Hunger AI-powered Full Cart Connect food-as-medicine platform — is resourced by the operating parent company.

The underlying operating company, Quest Diagnostics, provides clinical laboratory testing and diagnostic information services including molecular/PCR testing, serology, genetic testing, anatomic pathology, advanced genomics, and reproductive and women's health testing. It operates 2,000+ patient service centers and 7,700 patient access points, performs more than 200 million tests annually, and serves roughly half of U.S. physicians and hospitals. Specialty subsidiaries include AmeriPath (anatomic pathology), Cleveland HeartLab (cardiometabolic), Athena Diagnostics (neurology), Blueprint Genetics (rare-disease genetics, 70+ countries), PhenoPath and Dermpath Diagnostics (dermatopathology), Haystack Oncology (ctDNA MRD liquid biopsy, acquired 2023), and Pack Health (digital patient engagement, acquired 2022). The technology stack spans proprietary assay development, integrations with 850+ EHR systems, the Quest AI Companion for patient result interpretation, and AI-empowered analytics within Blueprint Genetics.

The business model is transaction-based, with per-test pricing billed primarily through payer reimbursement (the company reports in-network coverage of 90% of insured lives) and a growing direct-to-consumer channel via questhealth.com. Customer segments span physicians, hospitals and health systems, employers, health plans, life sciences companies, and individual consumers. Reported revenue was $9.88 billion in 2022 (elevated by COVID-19 testing) and was guided to $8.93B–$9.08B for 2023, with disclosed commentary indicating that base-business revenues were growing as pandemic-related testing volumes normalized.

Quest Diagnostics Foundation firmographics

Firmographics
Name
Quest Diagnostics Foundation
Legal name
Quest Diagnostics Incorporated
Website
https://questdiagnostics.com
Company type
Public
Founded year
1991
Operating status
Operating
Headcount range
5,001–10,000 employees
Short description
Quest Diagnostics Foundation is the 501(c)(3) charitable arm of Quest Diagnostics Incorporated (NYSE: DGX). The parent operates a national clinical laboratory network running 200+ million tests per year for half of U.S. physicians and hospitals, and the Foundation funds community health and wellness programs in partnership with public health and anti-hunger organizations.
Ownership category
akta.pro rank

Quest Diagnostics Foundation industry classification

Industry
Product category
Healthcare Philanthropy
NAICS
Grantmaking Foundations (813211), Voluntary Health Organizations (813212)
SIC
Services-Social Services (8300)
akta.pro primary industry
Health & Medical Research Grantmaking Foundations (BPAGAKAL)
akta.pro secondary industry
Community Health, Prevention & Health Education (BPAGACAC)

Keywords

  • Community health grants
  • Health equity programs
  • Disease prevention funding
  • Charitable health partnerships
  • Community wellness initiatives

Where Quest Diagnostics Foundation is headquartered

Location

Headquarters

HQ city
Secaucus
HQ country
United States
HQ region
North America

Offices8 records

Markets served

Quest Diagnostics Foundation business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Operations, Personnel, Marketing or Sales, Others

Revenue model

  1. Diagnostic Information Services: Clinical laboratory testing services provided to healthcare providers and patients, including routine and specialty tests across multiple disease categories.
  2. COVID-19 Testing: Molecular (PCR), rapid antigen, and antibody testing for SARS-CoV-2, with revenues declining post-pandemic from peak levels.
  3. Consumer-Initiated Testing: Direct-to-consumer lab tests purchased online through questhealth.com without doctor's order, including STI self-collection and various panel tests.
  4. Enterprise/B2B Services: Laboratory services for hospitals, health systems, employers, health plans, and life sciences companies including drug screening, population health, and clinical trials.
  5. Base Business Revenues: Core diagnostic testing revenues excluding COVID-19 testing, representing routine and specialty laboratory services.

Pricing tiers

ModelBillingPrice
Transaction based/ take ratePay-as-you-goStandard diagnostic testing services
Unit PricingPay-as-you-goConsumer-initiated testing (questhealth.com)
OtherPay-as-you-goFinancial assistance programs

Go-to-market motion4 records

Distribution channels6 records

Marketing channels8 records

Quest Diagnostics Foundation product offering

Product offering

Core offering

Quest Diagnostics Foundation is a 501(c)(3) nonprofit corporation that promotes healthcare and wellness benefits and disease prevention through grant-making and community health initiatives. The Foundation has committed approximately $53 million to community initiatives since 2021, awarding grants to nonprofits in cities such as Baltimore, Houston, Chicago, Paterson, and Miami-Dade County, with a focus on maternal health, cardiometabolic outcomes, food security, and health equity in underserved communities.

Product overview

Quest Diagnostics is a diagnostic information services company offering a comprehensive portfolio of laboratory tests and health technology solutions. The core offerings include MyQuest patient portal and Quanum Lab Services Manager for healthcare providers. Key specialty brands include AmeriPath (anatomic pathology), Cleveland HeartLab (cardiometabolic testing), Athena Diagnostics (neurological testing), Blueprint Genetics (genetic testing), and PhenoPath/Dermpath Diagnostics (dermatopathology/cancer diagnostics). The company recently acquired Haystack Oncology for minimal residual disease (MRD) liquid biopsy testing. Additional services include health coaching through Pack Health, thousands of routine and specialty lab tests, and population health solutions. Quest serves half of U.S. physicians and hospitals, with approximately 3,500+ lab tests available across 2,000+ patient service centers.

Differentiator

Problem solved

Functional benefit

Brands

  • Quanum Lab Services Manager: Online business tool for physicians, hospital, and office staff to order lab tests and view patient results
  • MyQuest
  • Quest Mobile
  • Quest Health
  • Haystack MRD
  • Cleveland HeartLab
  • AmeriPath
  • Athena Diagnostics
  • Pack Health

Products and services

  • Community Health Grants Program Grant-making program through which the Foundation awards funding to community-based nonprofit organizations working on health equity, maternal health, cardiometabolic disease prevention, and food security in underserved U.S. communities.
  • Healthy Communities Champions Award Recognition program honoring up to 15 individuals or organizations committed to improving health in their communities, each receiving a $5,000 grant to support their community health work.
  • Miami-Dade County Health Initiative Multi-year initiative committing nearly $5 million in grant funding to four local nonprofit organizations in Miami-Dade County, Florida, to improve chronic and maternal health outcomes and food security, with a goal of reaching up to 15,000 residents over a 2-year period.
  • Multi-Year Health Equity Initiative Joint $100+ million initiative launched by Quest Diagnostics and the Foundation to improve health, with initial focus on communities hit hardest by COVID-19 and continuing focus on health equity, chronic disease prevention, and community health workforce.

Quantifiable outcome

  • ApoB testing rates doubled between 2021-2023, reaching 1.8% of at-risk patients, though still extremely low relative to standard lipid panel testing
  • +2 more outcomes

Companies that use Quest Diagnostics Foundation

Customer profile

Named customers7 records

Segments7 records

Ideal customer profiles1 record

Quest Diagnostics Foundation technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration5 records

AI capability5 records

Feature9 records

Quest Diagnostics Foundation partnerships and signals

Strategic signal

Partnerships

Eleven partnerships are on record, tiered core, flagship and minor.

  • Florida International University FoundationcoreStrategic or Co-development Partner · 29 June 2026$5 million foundation grant for maternal health services across Miami-Dade County maternal health deserts, expanding Black Mothers Care Plan through mobile units and midwifery services.
  • Urban Health PartnershipscoreStrategic or Co-development Partner · 29 June 2026Foundation grant recipient coordinating Food and Nutrition for All Collaborative (FNFA), strengthening governance and shared data infrastructure, supporting mini-grants for up to 16 community organizations.
  • The Health Council of South FloridacoreStrategic or Co-development Partner · 29 June 2026Foundation grant recipient serving as evaluation partner to measure effectiveness of initiative, conducting equity-focused analysis of food access, maternal health, and chronic disease prevention.
  • U.S. HungercoreStrategic or Co-development Partner · 29 June 2026Foundation grant recipient deploying AI-powered Full Cart Connect Platform to identify and direct support to households in need throughout Miami-Dade County.
  • Hackensack Meridian Center for Discovery and Innovation (CDI)flagshipStrategic or Co-development Partner · 18 June 2026Collaborative research on antibiotic-resistant bacteria. Quest provided deidentified culture isolates from nationwide network for CDI sequencing analysis. Study published in Nature Communications identified multidrug-resistant Klebsiella pneumoniae spread across 42 states.
  • Haystack OncologycoreStrategic or Co-development Partner · 27 April 2023Quest acquired Haystack Oncology for $300 million (plus up to $150M milestones) to add minimal residual disease (MRD) liquid biopsy testing. Haystack developed tumor-informed ctDNA technology based on 20 years of Johns Hopkins research for early detection of residual or recurring cancer.
  • NewYork-PresbyteriancoreStrategic or Co-development Partner · 17 April 2023Quest completed acquisition of select laboratory services assets of NewYork-Presbyterian. Goal is to enable providers and patients to access high quality, affordable testing combining complementary strengths of both organizations with access to Quest's network of nearly 100 patient service centers.
  • Tower HealthcoreStrategic or Co-development Partner · 16 February 2023Quest provides laboratory supply chain expertise and reference testing for regional integrated healthcare system in Pennsylvania.
  • Pack HealthcoreStrategic or Co-development Partner · 18 January 2022Quest acquired Pack Health to add digital patient engagement and health coaching capabilities. Pack Health provides health coaching for chronic disease management programs, including diabetes, and expanded headquarters in Birmingham, Alabama with at least 200 new full-time jobs.
  • CDC (ICATT Program)flagshipStrategic or Co-development PartnerQuest is the only major laboratory provider in CDC's Increasing Community Access to Testing program supporting testing access for uninsured in underserved communities.
  • Mobile Care ChicagominorStrategic or Co-development PartnerCommunity partnership delivering healthcare services to vulnerable children in Chicago through mobile van services.

Scale indicators16 records

Recent moves7 records

Expansion highlights6 records

Quest Diagnostics Foundation competitors and assessment

Company assessment

Direct peers

  • Pfizer Foundation: Corporate foundation of a major pharmaceutical company funding community health, health workforce, and health-equity initiatives globally. Same corporate-foundation structure, comparable grant size, and overlap in target disease areas (cardiovascular, infectious disease).
  • Eli Lilly Foundation: Corporate foundation of a major pharmaceutical company supporting community health and disease-specific initiatives. Direct structural peer as a publicly traded pharma parent with a separately governed corporate foundation.
  • Bristol Myers Squibb Foundation: A major pharmaceutical corporate foundation funding health-equity, oncology, and cardiovascular community programs. Closely comparable in structure as a corporate-foundation grantmaker, with similar disease-area and disparities focus and grantee-driven delivery model.
  • Kaiser Permanente Community Health: Community health arm of a large integrated US health system, funding community health, maternal/child health, and chronic disease prevention in served and underserved markets. Comparable as a healthcare-organization grantmaker targeting similar disease areas and populations.
  • UnitedHealth Foundation: Corporate foundation of a major US health insurer funding community health, maternal/child health, and workforce initiatives. Closely comparable scale, grantmaking structure, and disease-area focus to the Quest Diagnostics Foundation.
  • ARUP Laboratories: Nonprofit academic clinical laboratory affiliated with the University of Utah, providing reference and esoteric diagnostic services. Closely comparable in business model (diagnostics) and nonprofit structure, making it the closest structural peer if the comparison expands to the Foundation's parent context.

Broad incumbents

  • Robert Wood Johnson Foundation: The largest US philanthropy focused exclusively on health, RWJF funds community health, maternal/child health, and health-equity initiatives across many markets. It is the benchmark independent health-focused grantmaking foundation and the most relevant peer for the Quest Diagnostics Foundation's mission and grantmaking model.
  • CDC Foundation: Independent nonprofit that mobilizes philanthropic and private-sector resources to support CDC priorities in public health, health equity, and disease prevention. Comparable as a public-health-focused grantmaking organization, though with broader public-sector and global scope.
  • Sonic Healthcare: Global clinical laboratory and diagnostic services company with US operations through affiliated brands. Comparable to Quest Diagnostics at the parent-company level in core diagnostics business, providing indirect context for the Foundation's strategic priorities.
  • Labcorp (Laboratory Corporation of America): Direct competitor to Quest Diagnostics Incorporated (the parent of the Foundation) in clinical laboratory services. Most relevant peer for the broader organization, though Labcorp's corporate foundation activities are a subset of its scale.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights6 records

Customer concentration

Quest Diagnostics Foundation social profiles

Digital presence

Quest Diagnostics Foundation compliance and trust

Trust signal

Compliance4 records

Quest Diagnostics Foundation financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Quest Diagnostics Foundation leadership team

Management profile

Number of profiles

Profiles1 record

Quest Diagnostics Foundation subsidiaries and ownership

Company hierarchy

Subsidiaries9 records

Quest Diagnostics Foundation funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Quest Diagnostics Foundation M&A and investment

M&A and investment

M&A

Investments3 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Quest Diagnostics Foundation

What does Quest Diagnostics Foundation do?

Quest Diagnostics Foundation is a 501(c)(3) nonprofit corporation that promotes healthcare and wellness benefits and disease prevention through grant-making and community health initiatives. The Foundation has committed approximately $53 million to community initiatives since 2021, awarding grants to nonprofits in cities such as Baltimore, Houston, Chicago, Paterson, and Miami-Dade County, with a focus on maternal health, cardiometabolic outcomes, food security, and health equity in underserved communities.

Is Quest Diagnostics Foundation a public or private company?

Quest Diagnostics Foundation is a public company. It is classified as nonprofit foundation owned and is currently operating.

When was Quest Diagnostics Foundation founded?

Quest Diagnostics Foundation was founded in 1991. It employs 5,001 to 10,000 people.

Where is Quest Diagnostics Foundation based?

Quest Diagnostics Foundation is headquartered in Secaucus, United States, in the North America region.

How does Quest Diagnostics Foundation make money?

Five revenue lines are on record. Diagnostic Information Services are the primary driver. The others are COVID-19 Testing, consumer-Initiated Testing, enterprise/B2B Services and base Business Revenues.

Who are Quest Diagnostics Foundation's main competitors?

Direct peers on record are Pfizer Foundation, Eli Lilly Foundation, Bristol Myers Squibb Foundation, Kaiser Permanente Community Health, UnitedHealth Foundation and ARUP Laboratories. Broad incumbents are Robert Wood Johnson Foundation, CDC Foundation, Sonic Healthcare and Labcorp (Laboratory Corporation of America).

Does Quest Diagnostics Foundation have an API?

No public API is recorded for Quest Diagnostics Foundation.

What industry is Quest Diagnostics Foundation in?

Quest Diagnostics Foundation's product category is Healthcare Philanthropy. Its primary akta.pro industry code is BPAGAKAL, Health & Medical Research Grantmaking Foundations, with a secondary code of BPAGACAC, Community Health, Prevention & Health Education. Its NAICS code is 813211 and its SIC code is 8300.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Florida Hospital News and Healthcare ReportQuest Diagnostics Foundation Commits Nearly $5 Million to Improving Health Outcomes and Food Security in Miami-Dade County, FloridaQuest Diagnostics Foundation has awarded nearly $5 million in grants to four local organizations to improve health outcomes and food security for up to 15,000 residents in Miami-Dade County over a two-year period. The initiative includes providing no-cost laboratory testing for chronic diseases and supporting community health workers, doulas, and nutritious food access through mobile clinics and education events. This effort is part of a broader multi-year strategy by the foundation to address health disparities in select U.S. cities.ConfermedConferMED, through Grant from the Quest Diagnostics Foundation, Now Providing Specialty eConsults to Front Line Primary Care Providers at Federally Qualified Health Centers in Five Key Metropolitan ArConferMED has launched a specialty eConsult program for Federally Qualified Health Centers in five U.S. metropolitan areas, funded by a $2.3 million grant from the Quest Diagnostics Foundation. The initiative aims to improve access to specialty care for approximately 400,000 uninsured and underinsured patients by enabling virtual consultations between primary care providers and board-certified specialists.PR NewswireConferMED, through Grant from the Quest Diagnostics Foundation, now Providing Specialty eConsults to Front Line Primary Care Providers at Federally Qualified Health Centers in Five Key Metropolitan ArConferMED has launched a specialty eConsult program for Federally Qualified Health Centers in five metropolitan areas, funded by a $2.3 million grant from the Quest Diagnostics Foundation. The initiative aims to improve access to care for approximately 400,000 uninsured and underinsured patients in Texas, Maryland, Massachusetts, Florida, and Illinois. Fifteen health centers have already signed up for the service to facilitate virtual consultations between primary care providers and specialists.PR NewswireBread of Life, Inc. teams up with the Quest Diagnostics Foundation and local community partners to improve access to healthcare and create job opportunities for underserved communitiesBread of Life, Inc. launched the Healthy Houston Collective program in partnership with the Quest Diagnostics Foundation to improve healthcare access and create job opportunities for underserved communities in Houston. The initiative is supported by a $3.8 million grant from Quest Diagnostics to address health disparities through community care, training, and collaborations with local health centers.CSRwireConferMED Awarded Grant From the Quest Diagnostics Foundation To Provide Specialty eConsults to Front Line Providers at Federally Qualified Health Centers in Key RegionsConferMED has been awarded a $2.3 million grant from the Quest Diagnostics Foundation to enhance its eConsult platform and provide specialty consultations to providers at Federally Qualified Health Centers in five specific U.S. regions. This initiative, part of the Quest for Health Equity program, aims to improve access to specialty care for underserved communities by enabling specialists to collaborate with primary care providers remotely.PR NewswireConferMED Awarded Grant from the Quest Diagnostics Foundation to Provide Specialty eConsults to Front Line Providers at Federally Qualified Health Centers in Key RegionsConferMED has been awarded a $2.3 million grant from the Quest Diagnostics Foundation to expand its specialty eConsult platform for providers at Federally Qualified Health Centers in five U.S. regions. This funding supports Quest Diagnostics' Quest for Health Equity initiative, aiming to improve access to specialty care and reduce health disparities in underserved communities.Quest DiagnosticsQuest Diagnostics NewsroomConferMED has been awarded a $2.3M grant from the Quest Diagnostics Foundation to enhance its eConsults platform for specialty care at Federally Qualified Health Centers across five U.S. regions. This initiative aims to improve access to specialty care and tackle healthcare disparities in underserved communities, particularly highlighted during the COVID-19 pandemic. The collaboration is expected to enhance patient outcomes by reducing barriers to specialty consultations.PR NewswireQuest Diagnostics Foundation to support Humanitarian Efforts in Ukraine with $500,000 gift to Project HOPEThe Quest Diagnostics Foundation announced a $500,000 donation to Project HOPE on March 15, 2022, to support humanitarian crisis relief efforts in Ukraine and for Ukrainian refugees in Eastern Europe. Project HOPE is coordinating with local organizations in Ukraine, Poland, Moldova, and Romania to deliver medical supplies and urgent assistance. Quest Diagnostics employees also contributed to the effort, with the Foundation matching their donations.PR NewswireQuest Diagnostics and Quest Diagnostics Foundation Launch Initiative to Reduce Health Disparities in Underserved CommunitiesQuest Diagnostics Incorporated and the Quest Diagnostics Foundation announced a multi-year initiative to address and reduce health disparities in underserved communities impacted by COVID-19. The initiative will provide donated testing services, education programs, partnerships, and financial support estimated to total more than $100 million, focusing on people of color, elderly, and homeless populations throughout the U.S. The company will partner with Federally Qualified Health Centers, long-term care facilities, schools, universities, and community organizations to close gaps in COVID-19 testing availability and address social determinants of health.